The landmark World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston at a pivotal moment for precision medicine. With rapid advances in genomic testing, companion diagnostics, digital pathology, spatial omics, multimodal analytics, and AI-enabled platforms, the summit will bring together more than 850 senior stakeholders across biopharma, diagnostics, regulatory, healthcare, CRO, testing lab, and technology communities to accelerate drug-diagnostic innovation and improve patient access to precision care.

Event Name: 16th World Clinical Biomarkers & Companion Diagnostics Summit

Event Date: October 5-8, 2026

Event Venue: The Westin Boston Seaport District, 425 Summer Street, Boston, MA 02210

Recent regulatory shifts, followed by a surge in Rx-Dx launches, expanded access in advanced genomic testing, rapid innovation in digital pathology, spatial omics, multimodal analytics and agentic AI diagnostic platforms, alongside sustained, sizeable investments, signal that precision medicine is entering a defining new era.

It is in this context that the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston, as your longest-standing definitive forum uniting the complete precision medicine ecosystem. Boasting an audience of 850+ senior stakeholders from biopharma, diagnostic, regulatory, healthcare, CRO, testing labs and multimodal communities, this remains the place to strengthen and build the necessary collaborations to accelerate drug-diagnosti  innovations from bench to bedside.

Be the first to see the newly released 4-day program.

To reflect the complex nature and rapid acceleration of novel endpoints and IVD advances, this year’s meeting will expand to five dedicated content tracks.

• Biomarker Discovery & Translation: Equip your translation development, biomarker discovery, biomarker operations and oncology teams with the insights needed to validate novel, highly translatable biomarker panels for both solid tissue and liquid biopsy diagnostic strategies.
• Clinical & CDx Development: Aimed at clinical development, medical affairs, CDx development, strategic partnerships and regulatory teams, this content will provide you with the toolkit to deliver compliant clinical trials, enrolment and monitoring workflows.
• Rx-Dx Commercialization & Adoption: Provide your pricing, reimbursement, market access, HOER and commercialization teams with access to the latest industry shifts and international payer evidence needs, to ensure rapid synchonrised, global adoption.
• Digital Pathology & Spatial Biomarkers: Designed for digital pathology, imaging, spatial biology and CDx development teams, this new track will dive into best-in- class ways to standardize analysis, boost throughput and improve reproducibility.
• Multimodal & AI-Enabled Precision Medicine: Offer your data science, RWE, AI & analytics and digital innovation teams, the chance to hear the cutting-edge data driving and ML-enabled biomarker discovery, clinical insights, and precision endpoints.

Convene with peers, benchmark strategies, forge new connections, stay informed on the latest industry trends and streamline your co development pipeline, at the industry’s leading touchpoint for precision medicine professionals.

Together let’s bring accessible, affordable precision healthcare to patients quicker.

Attendance is free* for drug developers and researchers.

*Subject to eligibility and Ts and Cs: visit the website to learn more.